Danaher (DHR)
(Delayed Data from NYSE)
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $326.58, moving +0.97% from the previous trading session.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $320.79, marking a +0.35% move from the previous day.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $319.68, marking a +1.83% move from the previous day.
General Electric (GE) Acquires BK Medical, To Buy Opus One
by Zacks Equity Research
General Electric's (GE) BK Medical acquisition is expected to boost its offerings in the ultrasound space. Also, Opus One, when acquired, will add vigor to GE Digital offerings to electric utilities.
3 Reasons Growth Investors Will Love Danaher (DHR)
by Zacks Equity Research
Danaher (DHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is Crane (CR) Stock Outpacing Its Conglomerates Peers This Year?
by Zacks Equity Research
Here is how Crane (CR) and Danaher (DHR) have performed compared to their sector so far this year.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $318.49, moving +1.11% from the previous trading session.
Bull of the Day: Mesa Laboratories (MLAB)
by Kevin Cook
Another solid quarter and growth ahead in genetic diagnostic services makes this small cap a buy
BRRAY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BRRAY vs. DHR: Which Stock Is the Better Value Option?
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Honeywell (HON) to Buy US Digital Designs, To Aid Public Safety
by Zacks Equity Research
Honeywell's (HON) US Digital Designs acquisition is expected to boost its offerings for improving public safety communications. US Digital Designs will be part of the Building Technologies segment.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $319.28, moving +0.32% from the previous trading session.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $312.94, marking a -0.99% move from the previous day.
The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Chevron, Medtronic and Danaher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Chevron, Medtronic and Danaher
Top Stock Reports for Microsoft, JPMorgan Chase & Chevron
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), JPMorgan Chase & Co. (JPM) and Chevron Corporation (CVX).
Danaher (DHR) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Zacks Industry Outlook Highlights: Danaher, Carlisle Companies, Raven Industries and Griffon Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Danaher, Carlisle Companies, Raven Industries and Griffon Corp
4 Must-Watch Stocks in Gloomy Diversified Operations Industry
by Payal Jalan
Supply-chain, logistics and labor woes are limiting growth in the Zacks Diversified Operations industry. Despite this, DHR, CSL, RAVN and GFF are showing strength and must be on investors' watch list.
General Electric (GE) Tops Q3 Earnings Estimates, Ups '21 View
by Zacks Equity Research
General Electric's (GE) Q3 earnings reflect the impacts of strength in Aviation, and weak Healthcare and Renewable Energy. It lowers 2021 Industrial organic revenue view and ups the same for earnings.
3M (MMM) Q3 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
3M's (MMM) third-quarter 2021 revenues increase 7.1% year over year on account of impressive performance across its segments.
Danaher (DHR) Beats on Q3 Earnings, Ups 2021 Core Sales View
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect healthy demand for products in its three segments and a better gross margin. Pandemic-induced demand too adds to sales growth. It raises the core sales view for 2021.
Honeywell (HON) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Honeywell's (HON) third-quarter 2021 revenues increase 9% year over year on account of impressive performance across all of its segments.
Carlisle (CSL) Q3 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) third-quarter 2021 revenues increase 24.5% year over year on account of impressive performance across its segments.